Solitaire™ FR as Primary Treatment for Acute Ischemic Stroke (SWIFT PRIME)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Covidien
Sponsor:
Information provided by (Responsible Party):
Covidien
ClinicalTrials.gov Identifier:
NCT01657461
First received: August 2, 2012
Last updated: June 24, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)